Project Grant R43AI195168
Award Date 8/25/25
Completion Date 7/31/27
Dollars Obligated $300K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Irvine, CA 92618, USA
Similar Awards
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855), supports the development of a next-generation carbohydrate-based multi-component vaccine against Bordetella pertussis, the bacterium that causes whooping cough. The $1,561,668 award to Michigan State University aims to synthesize novel pertussis-associated glycan antigens, conjugate them to a bacteriophage...
- The National Institute of Allergy and Infectious Diseases (NIAID), through the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), awarded a $212,265 Project Grant (R21AI182884) to the University of Georgia Research Foundation. The grant will fund research to understand the impact of maternal vaccination on newborn susceptibility and response to Bordetella pertussis, the causative agent of whooping cough. The project aims to utilize a novel mouse neonatal infection...
- This federal Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Program (CFDA 93.855), is supporting Immport Therapeutics Inc. (doing business as Antigen Discovery Inc.) to optimize the immunogenicity of novel vaccine candidates against cryptosporidiosis. The $300,000 grant, awarded on August 12, 2025, will fund the production of purified recombinant Cryptosporidium proteins to be evaluated in...
- The federal Project Grant award of $4,630,686 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The funding supports research aimed at translating a germline-targeting HIV envelope SOSIP trimer immunization strategy for eliciting broadly neutralizing antibodies in infants. The research, conducted by Weill Medical College of Cornell University, focuses on systematically testing the optimal...
- This $666,567 Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) on August 19, 2025, supports research aimed at determining the role of vaccine-induced Th17 cells in protective immunity against tuberculosis (TB). The principal objectives are to: 1) assess the contribution of vaccine-induced Th17 cells to early neutrophil recruitment and disease pathology, and 2) identify and validate biomarkers related to...
- This federal Project Grant award, valued at $448,573, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research (CFDA 93.855) program. The grant aims to develop analytical tools to address challenges in vaccine efficacy trials, such as diverse baseline immunity in target populations and the impact of emerging variants on vaccine-induced immunity. Key objectives include: 1) Developing an immunogenicity model to predict...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research (CFDA 93.855) program, is supporting the development of a unique vaccine to prevent future pandemics caused by emerging coronaviruses. The $755,225 award to Loyola University of Chicago aims to create a T cell-inducing mucosal vaccine targeting conserved coronavirus antigens, which could provide cross-protection against sarbecoviruses and...
- The federal Project Grant award was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The $3,178,626 award to Trustees of Tufts College, doing business as Tufts University School of Medicine, supports research to investigate the role of microfold (M) cells in the gastrointestinal epithelium during murine infection by the enteric pathogen Yersinia pseudotuberculosis. The research aims to study...
- The federal Project Grant award of $778,829.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research conducted by Emory University to characterize early-life B-cell and antibody-secreting cell development and function in the human spleen, in order to uncover mechanisms of adaptive immunity at birth. Key objectives include understanding the differences between...
- This $281,786 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) is funding the development of a safe and effective viral vector-based vaccine to induce humoral and cellular immune protection against Powassan virus (POWV) in a tick transmission model. The research aims to simultaneously engage the humoral (neutralizing antibody) and cellular immune mechanisms to...